KRAS, NRAS, BRAF, and PIK3CA mutations occur at different frequencies in CRC and exert distinct effects on tumor biology, including the composition and functional properties of the TME, particularly its immune component. The gene discussed is KRAS; the disease is colorectal carcinoma.